CN Stock MarketDetailed Quotes

002332 Zhejiang Xianju Pharmaceutical

Watchlist
  • 11.53
  • -0.12-1.03%
Trading Jun 17 13:31 CST
11.41BMarket Cap19.64P/E (TTM)

Zhejiang Xianju Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Zhejiang Xianju Pharmaceutical Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

Apr 25, 2024

Revenue(YoY)

1.04B

+8.42%
EPS(YoY)

0.15

+15.38%
Analyst Rating

Strong Buy

Jun 17, 2024

Zhejiang Xianju Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 5.514B--
--2024/FY-- / 4.734B--
--2023/FY4.123B / 4.307B--
--2022/FY4.380B / 4.594B--
--2021/FY4.337B / 4.629B--
--2020/FY4.019B / 3.993B--
--2019/FY3.709B / 4.057B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 5.514B--
--2024/FY-- / 4.734B--
--2023/FY4.123B / 4.307B--
--2022/FY4.380B / 4.594B--
--2021/FY4.337B / 4.629B--
--2020/FY4.019B / 3.993B--
--2019/FY3.709B / 4.057B--
--------
--------
--------

Unlock Free Earnings Estimates

Zhejiang Xianju Pharmaceutical Earnings Reports

  • Xianju Pharmaceutical: Report for the first quarter of 2024

    Apr 24 12:00 ET

  • Xianju Pharmaceutical: 2023 Annual Report

    Apr 24 12:00 ET

  • Xianju Pharmaceutical: 2023 Annual Report Summary

    Apr 24 12:00 ET

  • Xianju Pharmaceutical: Report for the third quarter of 2023

    Oct 25, 2023 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 17, 2024

    Strong Buy

    • Strong Buy

      81.82%

    • Buy

      18.18%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg